Rapport Therapeutics, Inc. (RAPP) News
Track canonical SquawkNews coverage tagged to RAPP, Rapport Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Rapport Therapeutics to participate in upcoming investor conferences
Rapport Therapeutics says it will participate in upcoming investor conferences, a clinical-stage biotech focused on small molecule precision medicines.
EQUITY | Sep 02, 2026, 11:07 AM UTC
L
RAPP - Rapport Therapeutics to Participate in Upcoming Investor Conferences
RAPP - Rapport Therapeutics to Participate in Upcoming Investor Conferences
EQUITY | Sep 02, 2026, 11:00 AM UTC
M
Rapport Therapeutics Reports Q2 Financials
Rapport Therapeutics releases Q2 financials
EQUITY | Aug 05, 2026, 11:01 AM UTC
M
RAPP: Leerink Initiates
Leerink Partners initiates coverage on Rapport Therapeutics with Outperform rating and $52 price target
EQUITY | Jun 24, 2026, 06:41 PM UTC
M
RAPP Initiated Outperform
RAPP initiated with an Outperform rating at Leerink with a price target of $52
EQUITY | Jun 24, 2026, 11:44 AM UTC
M
Banks Initiate Coverage
Multiple banks initiate coverage on various stocks with OUTPERFORM, BUY, and EQUAL WEIGHT ratings
EQUITY | Jun 24, 2026, 10:54 AM UTC